Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07443761

Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital.

There is a need for a structured registry to collect real-world data on patient characteristics, surgical strategies, perioperative outcomes, and long-term results. Such a registry will provide insights into quality of care, support benchmarking, and form the basis for clinical and translational research.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Benign Pancreas Tumor Chronic Disease Digestive System Diseases Digestive System Neoplasms Disease Attributes Endocrine Gland Neoplasms Endocrine System Diseases Malignant Pancreatic Neoplasm Neoplasms Neoplasms by Site Pancreatic Diseases Pancreatic Neoplasms Pancreatitis Pancreatitis, Chronic Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Antwerp

Edegem, Antwerp, 2650, Belgium

About this study

The objective of this study is to collect and register all clinical data on patients undergoing pancreatic surgery at Antwerp University Hospital. Data collection will include demographic information, medical history, preoperative workup, surgical details, postoperative outcomes, lab results, pathology results and long-term follow-up.

There is no intervention in this study; patient care will be done according to the current standard of care. The data will be used to further improve patient outcomes, identify risk factors for complications (both patient-specific and procedure-specific), investigate oncological outcomes and long-term patient survival, help predict exocrine and endocrine insufficiency, and identify patient populations in which specific screening for this is indicated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • benign indications for pancreatic surgery, including chronic pancreatitis, cystic lesions and IPMN
  • malignant indications for pancreatic surgery, including PDAC, duodenal carcinoma, pancreatic neuro-endocrine tumours, distal cholangiocarcinoma.

Exclusion criteria

  • indications for pancreatic resection caused by acute pancreatitis
  • pancreatic resection after abdominal trauma

Treatment and study plan

Primary outcomes

  1. 90-day mortality

    Time frame: 25 years

    90-day mortality

Secondary outcomes

  1. Establishment of a registry for patients undergoing pancreatic surgery - secondary outcome measures

    Time frame: 25 years

    • 30-day mortality
    • morbidity, expressed as specific postpancreatectomy complications ( = defined by the ISPGS (International Study Group for Pancreatic Surgery), i.e. POPF (postoperative pancreatic fistula), chyle leak, PPH (postpancreatectomy haemorrhage), bile leak and delayed gastric emptying), postoperative complications defined by the Clavien Dindo scoring and the CCI (comprehensive complication index)
    • duration of hospital stay
    • need for postoperative transfusion
    • development of exocrine- or endocrine insufficiency (through systematic postoperative function testing)
    • overall survival
    • disease free survival

Sponsors and collaborators

Lead sponsor

University Hospital, Antwerp

Other

Registry information

Official study title

Pancreatic Surgery Registry (PANREG)

Acronym: PANREG

Important dates

Study start
2025
Primary completion
2050
Study completion
2050
First posted
Mar 2, 2026
Registry last updated
Mar 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.